APA (7th ed.) Citation

Can, S., Çakıcı, V., Kahveci, G. B., Eroğlu, Ş., Tok, B., Uygun, G., . . . Gökmen, İ. (2026). Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer. Journal of Clinical Medicine, 15(7), 2805. https://doi.org/10.3390/jcm15072805

Chicago Style (17th ed.) Citation

Can, Süleyman, Veli Çakıcı, Gizem Bakır Kahveci, Şeyma Eroğlu, Burak Tok, Gökhan Uygun, Esra Özer, Yalçın Çırak, and İvo Gökmen. "Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer." Journal of Clinical Medicine 15, no. 7 (2026): 2805. https://doi.org/10.3390/jcm15072805.

MLA (9th ed.) Citation

Can, Süleyman, et al. "Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer." Journal of Clinical Medicine, vol. 15, no. 7, 2026, p. 2805, https://doi.org/10.3390/jcm15072805.